These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23513212)

  • 21. Implantable device diagnostics on day of discharge identify heart failure patients at increased risk for early readmission for heart failure.
    Small RS; Whellan DJ; Boyle A; Sarkar S; Koehler J; Warman EN; Abraham WT
    Eur J Heart Fail; 2014 Apr; 16(4):419-25. PubMed ID: 24464745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-Sustained Ventricular Tachycardia Episodes Predict Future Hospitalization in ICD Recipients with Heart Failure.
    Uçar FM; Yilmaztepe MA; Taylan G; Aktoz M
    Arq Bras Cardiol; 2017 Oct; 109(4):284-289. PubMed ID: 28977051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial.
    Conraads VM; Tavazzi L; Santini M; Oliva F; Gerritse B; Yu CM; Cowie MR
    Eur Heart J; 2011 Sep; 32(18):2266-73. PubMed ID: 21362703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A dynamic risk score to identify increased risk for heart failure decompensation.
    Sarkar S; Koehler J
    IEEE Trans Biomed Eng; 2013 Jan; 60(1):147-50. PubMed ID: 22835530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure.
    Vanderheyden M; Houben R; Verstreken S; Ståhlberg M; Reiters P; Kessels R; Braunschweig F
    Circ Heart Fail; 2010 May; 3(3):370-7. PubMed ID: 20197559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study.
    Muto C; Solimene F; Gallo P; Nastasi M; La Rosa C; Calvanese R; Iengo R; Canciello M; Sangiuolo R; Diemberger I; Ciardiello C; Tuccillo B
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):538-45. PubMed ID: 23592833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Burden of Implanted-Device-Detected Atrial High-Rate Episode Is Associated With Future Heart Failure Events　- Clinical Significance of Asymptomatic Atrial Fibrillation in Patients With Implantable Cardiac Electronic Devices.
    Nishinarita R; Niwano S; Fukaya H; Oikawa J; Nabeta T; Matsuura G; Arakawa Y; Kobayashi S; Shirakawa Y; Horiguchi A; Nakamura H; Ishizue N; Kishihara J; Satoh A; Ako J
    Circ J; 2019 Mar; 83(4):736-742. PubMed ID: 30814400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
    Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M
    Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remote monitoring: Doomed to let down or an attractive promise?
    Lucà F; Cipolletta L; Di Fusco SA; Iorio A; Pozzi A; Rao CM; Ingianni N; Benvenuto M; Madeo A; Fiscella D; Benedetto D; Francese GM; Gelsomino S; Zecchin M; Gabrielli D; Gulizia MM
    Int J Cardiol Heart Vasc; 2019 Sep; 24():100380. PubMed ID: 31193998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary experience with the multisensor HeartLogic algorithm for heart failure monitoring: a retrospective case series report.
    Capucci A; Santini L; Favale S; Pecora D; Petracci B; Calò L; Molon G; Cipolletta L; Bianchi V; Schirripa V; Santobuono VE; La Greca C; Campari M; Valsecchi S; Ammirati F; D'Onofrio A
    ESC Heart Fail; 2019 Apr; 6(2):308-318. PubMed ID: 30632306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trial.
    Botto GL; Boriani G; Favale S; Landolina M; Molon G; Tondo C; Biffi M; Grandinetti G; De Filippo P; Raciti G; Padeletti L
    Trials; 2011 Feb; 12():44. PubMed ID: 21324118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
    Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
    J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HeartLogic Multisensor Algorithm Identifies Patients During Periods of Significantly Increased Risk of Heart Failure Events: Results From the MultiSENSE Study.
    Gardner RS; Singh JP; Stancak B; Nair DG; Cao M; Schulze C; Thakur PH; An Q; Wehrenberg S; Hammill EF; Zhang Y; Boehmer JP
    Circ Heart Fail; 2018 Jul; 11(7):e004669. PubMed ID: 30002113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial fibrillation burden and subsequent heart failure events in patients with cardiac resynchronization therapy devices.
    Tanawuttiwat T; Lande J; Smeets P; Gerritse B; Nazarian S; Guallar E; Cheng A
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1519-1526. PubMed ID: 32162753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study.
    Sack S; Wende CM; Nägele H; Katz A; Bauer WR; Barr CS; Malinowski K; Schwacke H; Leyva F; Proff J; Berdyshev S; Paul V
    Eur J Heart Fail; 2011 Sep; 13(9):1019-27. PubMed ID: 21852311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patients.
    Smit MD; Van Dessel PF; Nieuwland W; Wiesfeld AC; Tan ES; Anthonio RL; Van Erven L; Van Veldhuisen DJ; Van Gelder IC
    Heart Rhythm; 2006 Dec; 3(12):1397-403. PubMed ID: 17161779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physical activity measured with implanted devices predicts patient outcome in chronic heart failure.
    Conraads VM; Spruit MA; Braunschweig F; Cowie MR; Tavazzi L; Borggrefe M; Hill MR; Jacobs S; Gerritse B; van Veldhuisen DJ
    Circ Heart Fail; 2014 Mar; 7(2):279-87. PubMed ID: 24519908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure.
    Stewart GC; Kittleson MM; Patel PC; Cowger JA; Patel CB; Mountis MM; Johnson FL; Guglin ME; Rame JE; Teuteberg JJ; Stevenson LW
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27834198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk stratification of cardiovascular and heart failure hospitalizations using integrated device diagnostics in patients with a cardiac resynchronization therapy defibrillator.
    Burri H; da Costa A; Quesada A; Ricci RP; Favale S; Clementy N; Boscolo G; Villalobos FS; Mangoni di S Stefano L; Sharma V; Boriani G;
    Europace; 2018 May; 20(5):e69-e77. PubMed ID: 28679168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF).
    Whellan DJ; O'Connor CM; Ousdigian KT; Lung TH;
    Am Heart J; 2008 Nov; 156(5):833-9, 839.e2. PubMed ID: 19061695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.